Docgo INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
DCGO
Docgo INCDocGo Inc. CEO Lee Bienstock reported a transaction involving the withholding of restricted stock units to cover tax liabilities, alongside details of his beneficial ownership of common stock and unvested RSUs.
NASDAQ
DCGO
Docgo INCDocGo Inc.'s CEO, Lee Bienstock, reported a transaction involving the withholding of 18,811 restricted stock units to cover tax liabilities.
NASDAQ
DCGO
Docgo INCDocGo CEO Lee Bienstock reported the acquisition of over 1.1 million restricted stock units and the disposition of 214,131 units for tax purposes.
NASDAQ
DCGO
Docgo INCDocGo Inc.'s CFO and Treasurer, Norman Rosenberg, reported the acquisition of 429,405 restricted stock units and the disposition of 65,774 shares for tax obligations.
NASDAQ
DCGO
Docgo INCDocGo's Chief Compliance Officer, Stephen Sugrue, reported the acquisition of 321,055 restricted stock units and the disposition of 35,968 units for tax obligations.
NASDAQ
DCGO
Docgo INCDocGo's General Counsel and Secretary, Ely D. Tendler, received a grant of 100,000 restricted stock units and sold 16,850 shares to cover tax obligations.
NASDAQ
DCGO
Docgo INCDocGo Inc. Director Michael J. Burdiek was granted 150,000 restricted stock units, vesting in December 2026, under the company's 2021 Stock Incentive Plan.
NASDAQ
DCGO
Docgo INCDocGo Inc. Director Etalvina Leite was granted 150,000 restricted stock units, vesting in December 2026, increasing her beneficial ownership to 201,411 shares.
NASDAQ
DCGO
Docgo INCDocGo Inc. Director Ira Smedra was granted 150,000 restricted stock units, vesting in December 2026, increasing his beneficial ownership to 240,999 shares.
NASDAQ
DCGO
Docgo INCDocGo Inc. Director James M. Travers was granted 150,000 restricted stock units, vesting in December 2026, as part of the company's 2021 Stock Incentive Plan.
NASDAQ
DCGO
Docgo INCDocGo Inc. Director Stephen K. Klasko, M.D. was granted 100,000 restricted stock units, vesting in September 2026.
NASDAQ
DCGO
Docgo INCDocGo's Chief Compliance Officer, Stephen Sugrue, reported the disposition of 5,813 common shares at $1.52 for tax obligations related to restricted stock units, retaining 351,515 shares.
NASDAQ
DCGO
Docgo INCDocGo Inc.'s CFO, Norman Rosenberg, has filed a Form 4 reporting a future disposition of 11,332 shares of common stock on July 2, 2025, to cover tax liabilities related to restricted stock units.
NASDAQ
DCGO
Docgo INCDocGo Inc. CEO Lee Bienstock filed a Form 4 detailing a future transaction on July 2, 2025, involving the withholding of 18,597 restricted stock units for tax purposes, alongside a comprehensive disclosure of his remaining RSU holdings and their future vesting dates.
NASDAQ
DCGO
Docgo INCDocGo Inc. Director Michael J. Burdiek has acquired 10,000 shares of common stock at $1.33 per share, increasing his direct beneficial ownership to 641,560 shares.
NASDAQ
DCGO
Docgo INCDirector Michael J. Burdiek purchased 15,000 shares of DocGo Inc. common stock at $1.43 per share on May 15, 2025, increasing his direct holdings to 631,560 shares.
NASDAQ
DCGO
Docgo INCDocGo's CEO, Lee Bienstock, disposed of 15,565 shares of common stock to cover tax liabilities related to previously granted restricted stock units (RSUs).
NASDAQ
DCGO
Docgo INCStephen K. Klasko, a director of DocGo Inc., purchased 15,000 shares of the company's common stock on May 14, 2025, at an average price of $1.49 per share.
NASDAQ
DCGO
Docgo INCStephen Sugrue, Chief Compliance Officer of DocGo Inc., purchased 10,000 shares of common stock at $1.44 per share on May 14, 2025, increasing his total holdings to 357,328 shares.
NASDAQ
DCGO
Docgo INCDocGo's CFO and Treasurer, Norman Rosenberg, recently purchased 15,000 shares of DocGo Inc. common stock at an average price of $1.47 per share.
NASDAQ
DCGO
Docgo INCDocGo's CEO, Lee Bienstock, purchased 15,000 shares of the company's common stock at a price of $1.54 per share on May 14, 2025.
NASDAQ
DCGO
Docgo INCChief Compliance Officer Stephen Sugrue of DocGo Inc. reports the withholding of restricted stock units to cover tax obligations.
NASDAQ
DCGO
Docgo INCNorman Rosenberg, CFO and Treasurer of DocGo Inc., reports the withholding of restricted stock units to cover tax liabilities.
NASDAQ
DCGO
Docgo INCDocGo's CEO, Lee Bienstock, reports the withholding of restricted stock units to cover tax liabilities.
NASDAQ
DCGO
Docgo INCStephen Sugrue, Chief Compliance Officer of DocGo Inc., reports acquisition and disposal of common stock related to the vesting of performance-based restricted stock units (RSUs).
NASDAQ
DCGO
Docgo INCNorman Rosenberg, CFO of DocGo Inc., reports acquisition and disposal of common stock and restricted stock units (RSUs) related to performance-based vesting and tax obligations.
NASDAQ
DCGO
Docgo INCForm 4: DocGo CEO Lee Bienstock Acquires Shares Through RSU Vesting, Disposes of Shares for Tax Obligations
DocGo's CEO, Lee Bienstock, reports the acquisition of shares through performance-based restricted stock units (RSUs) and the disposal of shares to cover tax liabilities.
NASDAQ
DCGO
Docgo INCChief Compliance Officer Stephen Sugrue of DocGo Inc. reports the withholding of restricted stock units to cover tax liabilities.
NASDAQ
DCGO
Docgo INCNorman Rosenberg, CFO and Treasurer of DocGo Inc., reports the withholding of restricted stock units to cover tax liabilities.
NASDAQ
DCGO
Docgo INCDocGo's CEO, Lee Bienstock, disposed of shares to cover tax liabilities related to previously granted restricted stock units (RSUs).